Correction To: Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.3% in Subjects With Bacterial Conjunctivitis: A Randomized Clinical Trial, by Baiza-Durán, L., Olvera-Montaño, O., Mercado-Sesma, A.R., and Oregon-Miranda, A.A. J Ocul Pharmacol Ther 2018;34(3):250-255. DOI:
Journal of Ocular Pharmacology and Therapeutics - United States
doi 10.1089/jop.2017.0056.correx
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2019
Authors
Unknown
Publisher
Mary Ann Liebert Inc